Watch Prof. Massimo Di Maio, Medical Oncologist, Head of the Medical Oncology Unit at Molinette Hospital (Turin), and President-elect of AIOM, discuss the strategic importance of Patient-Reported Outcomes (PROs) in late-stage research. He explains why integrating Quality of Life (QoL) as a key endpoint in Phase III & IV oncology trials is essential. Learn how new methods of large-scale data collection can capture the patient voice to deliver valuable and actionable insights for better treatments.